Middle East and Africa Cardiovascular Needle Market

Market Introduction

The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.

 Thus, the increasing prevalence of cardiovascular diseases are expected to create a significant demand for cardiovascular needle in the coming years, which is further anticipated to drive the cardiovascular needle market.

The coronavirus has had a significant impact in the Middle East and Africa. The pandemic has increased demand for medical devices, which can use in-home care. The region is witnessing an increase in the number of patients being admitted to intensive care units (ICU), an increasing number of drugs that pose multiple diagnostic and therapeutic challenges to strained health systems, leading to an increase in medical devices. Radiologists in South Africa have the highest number of COVID-19 infections in the country. You have seen changes in staff assignments and working hours and the implementation of strict infection control and social distancing measures. In addition, they face mental, physical, emotional, and financial challenges. Heart patients, especially those with heart failure and implantable devices, are at increased risk of COVID-19 morbidity and mortality. In addition, there is growing evidence that COVD-19 has significant and even long-term effects on the heart that can lead to an echo pandemic of patients with heart failure. With the ever-increasing costs associated with health care enrollment and the social distancing imposed by COVID-19. For this reason, market is going to have a negative impact in the review period.

Middle East and Africa Cardiovascular Needle Strategic Insights

Strategic insights for the Middle East and Africa Cardiovascular Needle provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Cardiovascular Needle Report Scope

Middle East and Africa Cardiovascular Needle Regional Insights

The geographic scope of the Middle East and Africa Cardiovascular Needle refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The cardiovascular needle market in Middle East and Africa is expected to grow from US$ 3,968.2 thousands in 2021 to US$ 6,189.7 thousands by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. Elderly people are at a high risk of heart diseases due to weakened immunity and other health issues. In general, aging leads to stiffening of heart muscles and blood vessels; moreover, the systolic blood pressure rises with aging. Thus, the people with the age 75 and above commonly suffer from hypertension, which may subsequently cause coronary artery disease and heart failure. According to the United Nation’s World Population Ageing 2017 report, around 962 million people were aged 60 years or above, and the number is expected to reach ~2.1 billion by 2050. The elderly population is known to have an atypical presentation of illness along with comorbidities and unfavourable outcomes. The major reason for the disease is related to age-related structural and functional changes in the cardiovascular system. Thus, the rising geriatric population, coupled with the surge in CVD prevalence among these people, is driving the cardiovascular needles market growth.

Key Market Segments

In terms of type, the round-bodied needles segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020. In terms of application, the open-heart surgery segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020. In terms of usage, the single use segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020. In terms of end user, the hospitals and clinics segment accounted for the largest share of the Middle East and Africa cardiovascular needle market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the cardiovascular needle market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., CP Medical, and SMB Corporation of India.

Reasons to buy report

• To understand the Middle East and Africa Cardiovascular needle market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa Cardiovascular needle market
• Efficiently plan M&A and partnership deals in Middle East and Africa Cardiovascular needle market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa Cardiovascular needle market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East and Africa region.

Middle East and Africa Cardiovascular Needle Market Segmentation    

By Application

• Open Heart Surgery
• Cardiac Valve Procedures

By Usage

• Single Use
• Multiple Uses

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centres
• Cardiovascular Centres

By Country

• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Companies Mentioned

1. Ethicon (Johnson & Johnson Services, Inc.)              
2. MANI, INC              
3. Barber of Sheffield             
4. FSSB surgical needles GmbH          
5. Medtronic              
6. Teleflex Incorporated       
7. Meril Life Sciences Pvt. Ltd.             
8. CP Medical             
9. SMB Corporation of India